PUBLISHER: The Business Research Company | PRODUCT CODE: 1942843
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942843
A fecal extraction system is a tool or apparatus designed for collecting fecal samples to identify potential pathogens, microbes, or parasite elements present within the stool.
The primary assays within fecal extraction systems encompass calprotectin, albumin, hemoglobin, and bile acids. Calprotectin, for instance, is a biochemical measurement used to detect protein levels in stools, aiding in identifying inflammation within the intestines. Various analysis methods such as microscopic, chemical, immunological, and microbiological tests are employed to detect indications like parasitic infections, viral infections, bacterial presence, and issues related to poor nutrient absorption. These systems find application across diverse end-user settings, including diagnostic centers, hospitals, clinics, ambulatory care facilities, and research centers.
Tariffs are impacting the faecal extraction systems market by increasing costs of imported plastics, reagents, assay kits, and precision diagnostic components used in sample collection and analysis systems. Diagnostic centers in North America and Europe are most affected due to reliance on imported consumables, while Asia-Pacific faces higher costs for export-oriented diagnostic manufacturing. These tariffs are increasing testing costs and procurement expenses. However, they are also encouraging domestic production of diagnostic consumables, regional supply chain strengthening, and innovation in cost-effective stool testing solutions.
The faecal extraction systems market research report is one of a series of new reports from The Business Research Company that provides faecal extraction systems market statistics, including faecal extraction systems industry global market size, regional shares, competitors with a faecal extraction systems market share, detailed faecal extraction systems market segments, market trends and opportunities, and any further data you may need to thrive in the faecal extraction systems industry. This faecal extraction systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The faecal extraction systems market size has grown strongly in recent years. It will grow from $1.7 billion in 2025 to $1.79 billion in 2026 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to increasing incidence of gastrointestinal infections, expansion of diagnostic laboratory networks, rising adoption of fecal biomarker testing, growth in parasitic disease screening, improved clinical awareness of gut health.
The faecal extraction systems market size is expected to see strong growth in the next few years. It will grow to $2.21 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to increasing demand for early disease detection, rising investments in advanced diagnostic assays, expansion of outpatient diagnostic services, growing focus on preventive healthcare, increasing adoption of automated laboratory workflows. Major trends in the forecast period include increasing adoption of automated sample collection systems, rising demand for rapid stool diagnostics, growing use of immunological and molecular assays, expansion of point-of-care testing solutions, enhanced focus on diagnostic accuracy and hygiene.
The rising prevalence of inflammatory bowel disease (IBD) is anticipated to drive the growth of the fecal extraction systems market in the coming years. IBD refers to a group of disorders characterized by chronic inflammation of the digestive system tissues. Fecal extraction systems are utilized for diagnosing, monitoring disease activity, guiding treatment, and predicting disease relapse and post-operative recurrence in individuals with inflammatory bowel disease. Consequently, the growing incidence of IBD boosts the demand for fecal extraction systems. For example, in September 2023, the Impact of IBD Report 2023 published by the IBD Clinical and Research Centre, a Canada-based organization dedicated to improving the lives of patients with Crohn's disease and ulcerative colitis, indicated that the prevalence of IBD was 825 per 100,000 in 2023, equating to over 320,000 individuals in Canada. With a projected annual increase of 2.44% in prevalence, it is estimated that 1.1% of the population, or 470,000 Canadians, will be living with IBD by 2035. Therefore, the increasing prevalence of inflammatory bowel disease is expected to propel the growth of the fecal extraction systems market.
Leading companies in the faecal extraction systems market are also innovating with products like colorectal cancer (CRC) screening tests, aimed at expanding their customer base, boosting sales, and increasing revenue. These screening tests are designed to detect colorectal cancer or precancerous conditions in individuals without symptoms. For example, in November 2023, Guardant Health introduced Shield, a blood-based colorectal cancer (CRC) screening test. The Shield assay identifies specific DNA characteristics indicative of cancer presence and demonstrated its efficacy in detecting colorectal cancer in average-risk individuals through the ECLIPSE registrational study, involving over 20,000 participants in the United States.
In March 2023, BGI Genomics Co., Ltd., a China-based healthcare technology company, entered into a partnership with Zentya to introduce COLOTECT 1.0, a non-invasive fecal DNA test designed for colorectal cancer screening in Slovakia. Through this collaboration, BGI Genomics Co., Ltd. sought to strengthen its presence in colorectal cancer screening across Slovakia and the broader Central and Eastern Europe region, while improving access to early detection via a locally distributed, non-invasive testing solution. Zentya, a Slovakia-based healthcare solutions provider, focuses on delivering advanced genetic screening technologies to patients, supporting the early identification and timely treatment of genetic diseases.
Major companies operating in the faecal extraction systems market are Alpha Laboratories Ltd., Arbor Assays, Buhlmann Laboratories AG, Calpro AS, DRG Instruments GmbH, Biohit Healthcare Ltd., Meridian Bioscience Inc., Quidel Corporation, DiaSorin SpA, Sekisui Diagnostics LLC, Abbott Laboratories, Roche Diagnostics Corporation, Randox Laboratories Ltd., Trinity Biotech plc, bioMerieux SA, Werfen SA, Mobidiag Oy, Hologic Inc., Siemens Healthineers, Beckman Coulter Inc., Thermo Fisher Scientific Inc.
North America was the largest region in the faecal extraction systems market in 2025. The regions covered in the faecal extraction systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the faecal extraction systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The faecal extraction system market consists of sales of stool pre-processing devices, and stool extraction devices,. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Faecal Extraction Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses faecal extraction systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for faecal extraction systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The faecal extraction systems market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.